Recognized as the original and leading annual forum for personalized medicine

Attracts recognized authorities and experts across healthcare and biotechnology sectors

Delivers the broadest and most up-to-date content across all facets of precision medicine in a collegial atmosphere.

Recognized as the original and leading annual forum for precision medicine

Attracts recognized authorities and experts across healthcare and biotechnology sectors

Delivers the broadest and most up-to-date content across all facets of precision medicine in a collegial atmosphere.

Session Themes

Patient Advocacy in Today’s Health Care System Session Chair: TBA

Patient Advocacy in Today’s Health Care System

Session Chair: TBA

Panel: How Patients Can Advance Precision Medicine and Why You Should Care Session Chair: Moira Quinn, Charlotte Center City Partners

Panel: How Patients Can Advance Precision Medicine and Why You Should Care

Session Chair: Moira Quinn, Charlotte Center City Partners

Trends in Comprehensive Study and Biological Sample Management Session Chair: TBA

Trends in Comprehensive Study and Biological Sample Management

Session Chair: TBA

Automating Evidence-based Gene Panel Design Session Chair: Mark Kiel, Genomenon, Inc.

Automating Evidence-based Gene Panel Design

Session Chair: Mark Kiel, Genomenon, Inc.

Call for Community Oncologists to Learn About Precision Medicine Session Chair: Vincent Miller, Foundation Medicine

Call for Community Oncologists to Learn About Precision Medicine

Session Chair: Vincent Miller, Foundation Medicine

Infrastructure and Computational Tools in Support of Research and Genomic Medicine Session Chair: Elaine R. Mardis, Nationwide Children’s Hospital

Infrastructure and Computational Tools in Support of Research and Genomic Medicine

Session Chair: Elaine R. Mardis, Nationwide Children’s Hospital

Value-Based Care Models Increase Patient Outcomes and Lower Healthcare Cost Session Chair: Andrew L. Pecora, Cota Healthcare Inc.

Value-Based Care Models Increase Patient Outcomes and Lower Healthcare Cost

Session Chair: Andrew L. Pecora, Cota Healthcare Inc.

Advancing Precision Medicine in Oncology: The Molecular Pathologist’s Role Session Chair: Chris Cournoyer, N-of-One

Advancing Precision Medicine in Oncology: The Molecular Pathologist’s Role

Session Chair: Chris Cournoyer, N-of-One

Accelerating Clinical Trials Using Comprehensive Liquid Biopsy Session Chair: John Strickler, Duke Cancer Institute

Accelerating Clinical Trials Using Comprehensive Liquid Biopsy

Session Chair: John Strickler, Duke Cancer Institute

Why Subsets are the Practice Session Chair: Scott Zeger, Johns Hopkins Bloomberg School of Public Health

Why Subsets are the Practice

Session Chair: Scott Zeger, Johns Hopkins Bloomberg School of Public Health

Informed Health Decisions Through Creating a Learning Ecosystem Session Chair: Kenneth J. Pienta, Johns Hopkins University

Informed Health Decisions Through Creating a Learning Ecosystem

Session Chair: Kenneth J. Pienta, Johns Hopkins University

ME/CFS: The Mysterious Illness Science Has Yet to Unravel Session Chair: Zaher Nahle, Solve ME/CFS Initiative

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

Session Chair: Zaher Nahle, Solve ME/CFS Initiative

Delivering Precision Oncology in the Genomics Era Session Chair: Rebecca Brandes, Agilent

Delivering Precision Oncology in the Genomics Era

Session Chair: Rebecca Brandes, Agilent

IT Solutions in Support of Molecular and Genetics Labs Session Chair: Chris Callahan, Sunquest

IT Solutions in Support of Molecular and Genetics Labs

Session Chair: Chris Callahan, Sunquest

Metabolomics and its Role in Precision Medicine Session Chair: John Ryals, Metabolon

Metabolomics and its Role in Precision Medicine

Session Chair: John Ryals, Metabolon

Status Quo of Genome Sequencing in Cancer & Beyond Session Chair: Charles M. Perou, GeneCentric Diagnostics

Status Quo of Genome Sequencing in Cancer & Beyond

Session Chair: Charles M. Perou, GeneCentric Diagnostics

An Update on the Precision Medicine Initiative Session Chair: Geoffrey Ginsburg, Duke University School of Medicine

An Update on the Precision Medicine Initiative

Session Chair: Geoffrey Ginsburg, Duke University School of Medicine

Human Genomics is Fueling Drug Discovery Session Chair: Aris Baras, Regeneron Genetics Center

Human Genomics is Fueling Drug Discovery

Session Chair: Aris Baras, Regeneron Genetics Center

The Value of Data Sharing Session Chair: Kathy Giusti, Multiple Myeloma Research Foundation

The Value of Data Sharing

Session Chair: Kathy Giusti, Multiple Myeloma Research Foundation

Reforming Clinical Trials Session Chair: Janet Woodcock, FDA

Reforming Clinical Trials

Session Chair: Janet Woodcock, FDA

Data Science to Advance Precision Medicine Session Chair: Eric Schadt, Icahn School of Medicine

Data Science to Advance Precision Medicine

Session Chair: Eric Schadt, Icahn School of Medicine

Why Patient Engagement is Important Session Chair: Frank Ingari, CureForward

Why Patient Engagement is Important

Session Chair: Frank Ingari, CureForward

Approaches towards Understanding and Enhancing Human Longevity Session Chair: Brad Perkins, Human Longevity

Approaches towards Understanding and Enhancing Human Longevity

Session Chair: Brad Perkins, Human Longevity

Leaders in Academia to Foster Collaborations Session Chair: Ralph Snyderman, Duke University

Leaders in Academia to Foster Collaborations

Session Chair: Ralph Snyderman, Duke University

Genomics & Precision Medicine in the “Real World” Session Chair: Jonathan S. Berg, UNC-Chapel Hill

Genomics & Precision Medicine in the “Real World”

Session Chair: Jonathan S. Berg, UNC-Chapel Hill

Single Cell Genomics: Emerging Applications Session Chair: John Mikszta, BD Technologies

Single Cell Genomics: Emerging Applications

Session Chair: John Mikszta, BD Technologies

New Trends and Emerging Technologies Session Chair: Mark Levin, Third Rock Ventures

New Trends and Emerging Technologies

Session Chair: Mark Levin, Third Rock Ventures

Reimbursements – The Payor Perspective Session Chair: Lee Newcomer, UnitedHealthcare

Reimbursements – The Payor Perspective

Session Chair: Lee Newcomer, UnitedHealthcare

Novel Approaches to Infectious Disease Diagnosis Session Chair: Christopher W. Woods, Duke University

Novel Approaches to Infectious Disease Diagnosis

Session Chair: Christopher W. Woods, Duke University

Mobile Health is Changing Healthcare Session Chair: Eric Perakslis, Takeda

Mobile Health is Changing Healthcare

Session Chair: Eric Perakslis, Takeda

Liquid Biopsy is Propelling Cancer Diagnostics Research Session Chair: John Beeler, Inivata

Liquid Biopsy is Propelling Cancer Diagnostics Research

Session Chair: John Beeler, Inivata

The Role of the Human Microbiome Session Chair: Lawrence David, Duke University

The Role of the Human Microbiome

Session Chair: Lawrence David, Duke University

CRISPR – The Genome Engineering Revolution Session Chair: Charles Gersbach, Duke

CRISPR – The Genome Engineering Revolution

Session Chair: Charles Gersbach, Duke

Recent Developments in Cancer Immunology & Immunotherapy Session Chair: Charles Nicolette, Argos Therapeutics

Recent Developments in Cancer Immunology & Immunotherapy

Session Chair: Charles Nicolette, Argos Therapeutics

Testimonials

Conference Co-Hosts

HONOREES

SPEAKERS

Roger
Bonnie_Anderson
robert-califf
sam+hawgood
leroy+hood
Kathy-Hudson
timothy+triche
keith+yamamoto
peter-yu
anna+barker
rory+collins
george+sledge
mark+beggs

PREVIOUS PMWC SILICON VALLEY
6,500+ ATTENDEES
950+ SPEAKERS
MULTIDISCIPLINARY AUDIENCE

2015: 1200+ATTENDEE OVERVIEW

Visible Growth